Skip to main content
Clinical Genetics Branch (CGB)
A | B | C
| D | E | F | G
| H | I | J
| L | M
| N | O | P | Q | R | S
| T | U | V | W
| X | Y | Z
- Castle, Philip E., Ph.D.
Dr. Castle’s interests are the science and translation of cancer prevention strategies; global health disparities research; epidemiology of human papillomaviruses (HPV) and cervical/anogenital cancer.
- Chaturvedi, Anil K., Ph.D.
Role of HPV in the etiology of head and neck cancers, natural history of head and neck cancer precursors, inflammation and cancer risk, role of inflammation in the etiology of lung cancer and other smoking-associated cancers.
- Clarke, Megan A., Ph.D., M.H.S.
Dr. Clarke conducts research combining molecular, clinical, and population-based approaches to address etiology, prevention, and early detection of anogenital, cervical, and endometrial cancers.
- Gadalla, Shahinaz, Ph.D., M.B.Bch.
Dr. Gadalla’s research interests focus on identifying and characterizing individuals at high risk of developing cancer and discovering predictive and prognostic biomarkers that may guide therapeutic decisions for those patients.
- Goldstein, Alisa M., Ph.D.
Genetic epidemiology of cancer, integrating epidemiologic, clinical, and molecular approaches. Developing and evaluating methods to examine gene-environment interactions in complex diseases.
- Jeronimo, Jose A., M.D.
cervical cancer, lesion clonality, topography, visual natural history
- Katki, Hormuzd A., Ph.D.
Predicting cervical cancer risk. Estimating absolute risks from studies nested within cohorts. Efficient study designs for comparing diagnostic tests. Methodology for clinical genetics.
- Khincha, Payal, MBBS, MSHS
Clinical evaluations and genetics epidemiology of individuals with Li-Fraumeni Syndrome. Diagnostic methods and clinical management of dyskeratosis congenita (DC), a cancer-prone inherited bone marrow failure syndrome and telomere biology disorder (TBD).
- McReynolds, Lisa, M.D., Ph.D.
Inherited predisposition to hematopoietic malignancies, investigating both germline and somatic mutations effect on disease and transplant outcomes.
- Mirabello, Lisa, Ph.D.
Osteosarcoma etiology and risk factors and carcinogenic HPV genomics
- Sargen, Michael, M.D.
Studies the clinical, histopathologic, and genetic characteristics of melanoma-prone families. Also uses epidemiologic and molecular approaches to investigate risk factors for sebaceous carcinoma and other rare cutaneous malignancies.
- Savage, Sharon A., M.D.
Genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and inherited cancer predisposition syndromes.
- Schiffman, Mark, M.D., M.P.H.
Molecular epidemiology to study the natural history of human papillomavirus infection on the risk of cervical cancer. Applications for cervical cancer prevention.
- Stewart, Douglas, M.D.
Cancer risk and phenotype in the DICER1 syndrome and neurofibromatosis type 1. Gene identification in familial tumor-predisposition disorders.
- Wentzensen, Nicolas, M.D., Ph.D.
Etiology of cervical, ovarian, and endometrial cancer. HPV - related carcinogenesis. Discovery and translation of biomarkers for gynecological cancers. Gene methylation.